Responses
Oncology
Protocol
Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.